Citation Impact
Citing Papers
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Clinical trials in primary hepatocellular carcinoma: current status and future directions
1988
A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy
1991
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats
1990
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Therapy for cutaneous melanoma: An update
1990
Clinical applications of quinone-containing alkylating agents
2000
Phase II evaluation of gallium nitrate by continuous infusion in breast cancer
1989
Chemotherapy in malignant mesothelioma: a review
1991
Molecular mechanisms of cisplatin resistance
2011 Standout
Controlled drug delivery vehicles for cancer treatment and their performance
2018 Standout
The Epidemiology of Skin Cancer
1996 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Quinoline, quinazoline and acridonealkaloids
2007 Standout
Analysis of anticancer drugs: A review
2011 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Management of malignant pleural effusions
2001 Standout
Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
1994
Phantom auditory perception (tinnitus): mechanisms of generation and perception
1990 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Gallium in Cancer Treatment
2004
In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines
1997
Chemotherapy of gastric cancer
1988
Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy
1984
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The pharmacology and clinical uses of tamoxifen
1984
A potent specific pure antiestrogen with clinical potential.
1991 Standout
Anthracycline antitumour agents
1986
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials
1992
Toxic effects of metals
1991 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Stretchable and Soft Electronics using Liquid Metals
2017 Standout
High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993
1999 Standout
Uncommon heavy metals, metalloids and their plant toxicity: a review
2008 Standout
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
New agents in non-small cell lung cancer
1984
Mechanisms of Therapeutic Activity for Gallium
1998
Metabolism and possible health effects of aluminum.
1986
Preclinical studies identifying carboplatin as a viable cisplatin alternative
1985
Works of Baker Lh being referenced
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study.
1982
American experience with carminomycin.
1979
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.
1985
Phase I study of echinomycin.
1987
Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
1978
Preliminary experiences with intra-arterial adriamycin.
1977
Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.
1987
Evaluation of gallium nitrate in metastatic or locally recurrent squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
1984
Phase II trial of tamoxifen in malignant melanoma.
1982
Phase I-II clinical trial of gallium nitrate (NSC-15200).
1980
Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
1976
Phase II study of AMSA in lung cancer.
1981
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
1977
Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
1976
Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.
1983
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
1984
Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study.
1982